SUCHA, Rita, Martina KUBICKOVA, Jakub CERVENKA, Marian HRUSKA-PLOCHAN, Dáša BOHAČIAKOVÁ, Katerina KEPKOVA VODICKOVA, Tereza NOVAKOVA, Katerina BUDKOVA, Andrej SUSOR, Martin MARSALA, Jan MOTLIK, Hana KOVAROVA and Petr VODICKA. Targeted mass spectrometry for monitoring of neural differentiation. Biology Open. CAMBRIDGE: COMPANY BIOLOGISTS LTD, 2021, vol. 10, No 8, p. 1-13. ISSN 2046-6390. Available from: https://dx.doi.org/10.1242/bio.058727.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Targeted mass spectrometry for monitoring of neural differentiation
Authors SUCHA, Rita (203 Czech Republic), Martina KUBICKOVA (203 Czech Republic), Jakub CERVENKA (203 Czech Republic), Marian HRUSKA-PLOCHAN, Dáša BOHAČIAKOVÁ (703 Slovakia, belonging to the institution), Katerina KEPKOVA VODICKOVA (203 Czech Republic), Tereza NOVAKOVA (203 Czech Republic), Katerina BUDKOVA (203 Czech Republic), Andrej SUSOR, Martin MARSALA (203 Czech Republic), Jan MOTLIK (203 Czech Republic), Hana KOVAROVA (203 Czech Republic) and Petr VODICKA (203 Czech Republic, guarantor).
Edition Biology Open, CAMBRIDGE, COMPANY BIOLOGISTS LTD, 2021, 2046-6390.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10602 Biology , Evolutionary biology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.643
RIV identification code RIV/00216224:14110/21:00119648
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1242/bio.058727
UT WoS 000692170900005
Keywords in English Neural stem cell; Neural differentiation; Selected reaction monitoring; Mass spectrometry; Cell line characterization; Protein marker
Tags 14110517, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 15/2/2022 09:15.
Abstract
Human multipotent neural stem cells could effectively be used for the treatment of a variety of neurological disorders. However, a defining signature of neural stem cell lines that would be expandable, non-tumorigenic, and differentiate into desirable neuronal/glial phenotype after in vivo grafting is not yet defined. Employing a mass spectrometry approach, based on selected reaction monitoring, we tested a panel of well-described culture conditions, and measured levels of protein markers routinely used to probe neural differentiation, i.e. POU5F1 (OCT4), SOX2, NES, DCX, TUBB3, MAP2, S100B, GFAP, GALC, and OLIG1. Our multiplexed assay enabled us to simultaneously identify the presence of pluripotent, multipotent, and lineage committed neural cells, thus representing a powerful tool to optimize novel and highly specific propagation and differentiation protocols. The multiplexing capacity of this method permits the addition of other newly identified cell type-specific markers to further increase the specificity and quantitative accuracy in detecting targeted cell populations. Such an expandable assay may gain the advantage over traditional antibody-based assays, and represents a method of choice for quality control of neural stem cell lines intended for clinical use.
Links
GJ15-18316Y, research and development projectName: Úloha microRNA v řízení buněčného dělení a diferenciace lidských embryonálních kmenových buněk do neurálních kmenových buněk. (Acronym: miRNA v diferenciaci lidských EK buněk)
Investor: Czech Science Foundation
PrintDisplayed: 23/7/2024 17:41